Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(66.7%)
Phase 1
1(33.3%)
3Total
Phase 4(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05680623Completed

Clinical and Economic Validation of the ISGPS Definition of PPAP

Role: collaborator

NCT02281799Phase 4Withdrawn

Thiopurine Induced Pancreatitis in IBD Patients

Role: collaborator

NCT02754609Phase 1Completed

Hookworm Therapy for Coeliac Disease

Role: collaborator

NCT00749047Phase 4Unknown

How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?

Role: lead

All 4 trials loaded